pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
PUBLIC COMPANY
save

$XNCRXencor Inc

$XNCR26.80-2.62%
Pasadena, CA, USupdated 3h ago
Website ↗SEC EDGAR ↗Yahoo Finance ↗
community read0 votes
pipeline
1
marketed
0
phase 3
0
catalysts ytd
3
approvals ytd
0
recalls ytd
0

Pipeline(1)

pipeline depth1 products
Phase 1: 1
1Phase 1
Phase 1
emaretamig
Adenocarcinoma Of The Gastroesophageal Junction

📅 Upcoming

Nov 4, 2026
earnings
$XNCR26.80-2.62%
in 3mo
Xencor Inc earnings
Xencor Inc
→

🕒 Recent(90d)

nothing in the last 90 days
view all catalysts →

Insider activity

source: SEC Form 4

open-market buys + sells

  • Apr 10, 26SELLCornelissen Bart Jan· SR. VICE PRESIDENT & CFO3,499 sh @ $12.29−$43K↗
  • Mar 6, 26SELLDahiyat Bassil I· PRESIDENT & CEO6,606 sh @ $11.02−$73K↗
  • Mar 6, 26SELLDesjarlais John R· SR. VICE PRESIDENT & CSO2,502 sh @ $11.02−$28K↗
  • Mar 6, 26SELLEckert Celia· SVP, GENERAL COUNSEL1,767 sh @ $11.02−$19K↗
  • Mar 5, 26SELLDahiyat Bassil I· PRESIDENT & CEO14,870 sh @ $11.25−$167K↗
  • Mar 5, 26SELLDesjarlais John R· SR. VICE PRESIDENT & CSO4,118 sh @ $11.25−$46K↗
  • Mar 5, 26SELLEckert Celia· SVP, GENERAL COUNSEL3,244 sh @ $11.25−$36K↗
  • Mar 5, 26SELLCornelissen Bart Jan· SR. VICE PRESIDENT & CFO2,517 sh @ $11.25−$28K↗
  • Mar 3, 26SELLDahiyat Bassil I· PRESIDENT & CEO6,758 sh @ $11.90−$80K↗
  • Mar 3, 26SELLDesjarlais John R· SR. VICE PRESIDENT & CSO2,663 sh @ $11.90−$32K↗
  • Mar 3, 26SELLEckert Celia· SVP, GENERAL COUNSEL1,492 sh @ $11.90−$18K↗
routine RSU / option mechanics (6)
  • Mar 2, 26grantDesjarlais John R · SR. VICE PRESIDENT & CSO24,907 sh
  • Mar 2, 26grantDesjarlais John R · SR. VICE PRESIDENT & CSO149,440 sh
  • Mar 2, 26grantCornelissen Bart Jan · SR. VICE PRESIDENT & CFO19,458 sh
  • Mar 2, 26grantCornelissen Bart Jan · SR. VICE PRESIDENT & CFO116,750 sh
  • Mar 2, 26grantEckert Celia · SVP, GENERAL COUNSEL18,680 sh
  • Mar 2, 26grantEckert Celia · SVP, GENERAL COUNSEL112,080 sh
🐶 Hiring Signal
next earnings Nov 4, 2026
No open roles indexed yet — view Xencor Inc jobs →

News

no news has mentioned this company yet
identifiers
ticker
$XNCR
SEC CIK
0001326732
country
US
source
sec_tickers
top tags
Oncology1
mentioned in
0news items
entity-linker matched
Data sources
SEC EDGAR · openFDA
last refreshed 14m ago
Found something off?
🐶 something off?

Report a data issue

Tell Bork what looks wrong — wrong sponsor, stale phase, mislinked ticker, anything. We’ll triage and fix.

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?